Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for double-J ureteral stent–related lower urinary tract symptoms
2015-004013-25Phase 3Terminated
- Sponsor
- Institute of Molecular Medicine and Biomedical Research
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Lithiasis and Micturition disorder comparing Mirabegron with Placebo (2 arms). Primary endpoint: Primary urinary symptom endpoint. Started Jul 2016; status: terminated.
02
Drugs
mirabegron
03
Conditions
LithiasisMicturition disorder
Beyond the preview
Go deeper on 2015-004013-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004013-25.